Skip to main content

Table 5 Triglycerides (mg/dL) in the 19 patients who completed the study

From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

 

Argicolina

Normolip

Argicolina/Normolip rate

At start of treatment

104.2

97.6

106.8 (96.3118.4)

At end of treatment

86.9*

93.1

93.3 (81.0107.4)

Final / Initial %

83.4 (72.0 96.5)

95.4 (85.9106.0)

87.4 (73.3104.1)

  1. Data are expressed as geometric mean (95% CI) and analyzed by Student’s t test for paired data (end vs. start of treatment) after logarithmic transformation, * p < 0.05